Search for: "Ariad Pharmaceuticals Inc."
Results 41 - 60
of 103
Sort by Relevance
|
Sort by Date
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
13 Apr 2010, 10:26 am
See generally Ariad Pharmaceuticals, Inc. v. [read post]
12 Apr 2010, 11:44 am
Following on the heels of the Federal Circuit en banc opinion in Ariad Pharmaceuticals, Inc. v. [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV challenge: Meda… [read post]
29 Mar 2010, 4:34 pm
Ariad Pharmaceuticals, Inc. v. [read post]
29 Mar 2010, 4:34 pm
Ariad Pharmaceuticals, Inc. v. [read post]
26 Mar 2010, 4:15 am
Court of Appeals for the Federal Circuit confirmed March 22 that Section 112 of the Patent Act contains a separate written description requirement beyond the requirement that a patent’s claims be enabled in the specification (Ariad Pharmaceuticals Inc. v. [read post]
25 Mar 2010, 1:43 pm
In Ariad Pharmaceuticals, Inc. v. [read post]
24 Mar 2010, 3:23 pm
Monday the Federal Circuit released its en banc opinion in Ariad Pharmaceuticals, Inc. v. [read post]
24 Mar 2010, 11:33 am
Ariad Pharmaceuticals et al v. [read post]
24 Mar 2010, 4:45 am
Synthon Pharmaceuticals, Inc. [read post]
23 Mar 2010, 6:00 am
Ariad Pharmaceuticals, Inc. v. [read post]
22 Mar 2010, 9:15 pm
Earlier today, the Federal Circuit Court of Appeals published their en banc opinion in Ariad Pharmaceuticals, Inc. v. [read post]
22 Mar 2010, 8:52 pm
The en banc opinion addressed all of Ariad's arguments, and found in favor... [read post]
22 Mar 2010, 12:17 pm
Today, the Federal Circuit finally released its long-awaited opinion in Ariad Pharmaceuticals, Inc. v. [read post]
22 Mar 2010, 8:44 am
Ariad Pharmaceuticals, Inc. v. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
16 Dec 2009, 3:39 am
: Ariad Pharmaceuticals, Inc. v. [read post]
14 Dec 2009, 9:59 pm
Noonan -- At the outset of the en banc oral argument in Ariad Pharmaceuticals, Inc. v. [read post]
